TETRAPHASE PHARMACEUTICALS INC 4
4 · TETRAPHASE PHARMACEUTICALS INC · Filed Sep 18, 2013
Insider Transaction Report
Form 4
CMEA VENTURES VI LP
10% Owner
Transactions
- Sale
Common Stock
2013-09-16$9.22/sh−44,207$407,589→ 2,112,923 total - Sale
Common Stock
2013-09-17$9.48/sh−8,012$75,954→ 2,104,911 total - Sale
Common Stock
2013-09-16$9.22/sh−1,057$9,746→ 50,519 total - Sale
Common Stock
2013-09-17$9.48/sh−192$1,820→ 50,327 total
Footnotes (2)
- [F1]The shares are directly held by CMEA Ventures VI, L.P. ("CMEA VI"). The general partner of CMEA VI is CMEA Ventures VI Management, L.P. ("CMEA VI GP"). The general partners of CMEA VI GP are Thomas R. Baruch ("Baruch"), David J. Collier ("Collier"), Faysal A. Sohail ("Sohail"), and James F. Watson ("Watson") and, as such, each of these individuals exercises shared voting and investment power over the shares held of record by CMEA VI. Each of the filing persons disclaims beneficial ownership of the shares except to the extent of their pecuniary interest therein, if any.
- [F2]The shares are directly held by CMEA Ventures VI GmbH & Co. KG ("CMEA VI GmbH"). The managing limited partner of CMEA VI GmbH is CMEA VI GP. The general partners of CMEA VI GP are Baruch, Collier, Sohail, and Watson and, as such, each of these individuals exercises shared voting and investment power over the shares held of record by CMEA VI GmbH. Each of the filing persons disclaims beneficial ownership of the shares except to the extent of their pecuniary interest therein, if any.